Data gathered: September 17
Alternative Data for Ginkgo Bioworks Holdings
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 6 | Sign up | Sign up | Sign up |
| Sentiment | 68 | Sign up | Sign up | Sign up |
| Webpage traffic | 52,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,041 | Sign up | Sign up | Sign up |
| Instagram Followers | 12,380 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 8 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 13,257 | Sign up | Sign up | Sign up |
| Twitter Followers | 33,676 | Sign up | Sign up | Sign up |
| Twitter Mentions | 305 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 19 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,214 | Sign up | Sign up | Sign up |
About Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming.
| Price | $7.15 |
| Target Price | Sign up |
| Volume | 1,430,000 |
| Market Cap | $351M |
| Year Range | $5.36 - $62 |
| Dividend Yield | 0% |
| Industry | Biotechnology |
In the news
 |
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Given Consensus Recommendation of “Reduce” by AnalystsSeptember 17 - ETF Daily News |
|
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Zurcher Kantonalbank Zurich CantonalbankSeptember 11 - ETF Daily News |
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNASeptember 4 - GlobeNewswire |
|
|
Ginkgo Bioworks (NYSE:DNA) Trading Down 3.8%August 26 - ETF Daily News |
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)August 26 - TipRanks |
|
 |
Ginkgo Bioworks (NYSE:DNA) Price Target Raised to $7.00 at BTIG ResearchAugust 24 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 56M | 136M | -80M | -217M | -206M | -2.800 |
| Q1 '24 | 50M | 83M | -34M | -166M | -165M | -0.080 |
| Q4 '23 | 8.7M | 102M | -93M | -212M | -165M | -0.110 |
| Q3 '23 | 70M | 182M | -112M | -303M | -265M | -0.160 |
| Q2 '23 | 95M | 106M | -11M | -173M | -166M | -0.090 |
Insider Transactions View All
| Coen Steven P. filed to sell 5,609 shares at $6.2. September 16 '24 |
| Dmytruk Mark E. filed to sell 28,749 shares at $6.2. September 16 '24 |
| Dmytruk Mark E. filed to sell 1,088,186 shares at $0.3. August 6 '24 |
| Coen Steven P. filed to sell 207,318 shares at $0.3. August 6 '24 |
| Dmytruk Mark E. filed to sell 1,043,626 shares at $0.3. July 5 '24 |
Similar companies
Read more about Ginkgo Bioworks Holdings (DNA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Ginkgo Bioworks Holdings?
The Market Cap of Ginkgo Bioworks Holdings is $351M.
What is the current stock price of Ginkgo Bioworks Holdings?
Currently, the price of one share of Ginkgo Bioworks Holdings stock is $7.15.
How can I analyze the DNA stock price chart for investment decisions?
The DNA stock price chart above provides a comprehensive visual representation of Ginkgo Bioworks Holdings' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ginkgo Bioworks Holdings shares. Our platform offers an up-to-date DNA stock price chart, along with technical data analysis and alternative data insights.
Does DNA offer dividends to its shareholders?
As of our latest update, Ginkgo Bioworks Holdings (DNA) does not offer dividends to its shareholders. Investors interested in Ginkgo Bioworks Holdings should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ginkgo Bioworks Holdings?
Some of the similar stocks of Ginkgo Bioworks Holdings are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.